Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Raymakers

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Bone Marrow Transplantation|August 4, 2015
Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysisS Slot, K Smits, N W C J van de Donk, et al.
Bone Marrow Transplantation|July 20, 2007
Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusionH Levenga, R Woestenenk, A V Schattenberg, et al.
Bone Marrow Transplantation|January 16, 2008
Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcomeM C Minnema, N W C J van de Donk, S Zweegman, et al.
Blood|July 13, 2000
Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Belgium-Dutch Hematology-Oncology GroupP Willems, O Verhagen, C Segeren, et al.
Leukemia|August 2, 2017
Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trialH Goldschmidt, H M Lokhorst, E K Mai, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Bone Marrow Transplantation|August 4, 2015
Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysisS Slot, K Smits, N W C J van de Donk, et al.
Bone Marrow Transplantation|July 20, 2007
Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusionH Levenga, R Woestenenk, A V Schattenberg, et al.
Bone Marrow Transplantation|January 16, 2008
Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcomeM C Minnema, N W C J van de Donk, S Zweegman, et al.
Blood|July 13, 2000
Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Belgium-Dutch Hematology-Oncology GroupP Willems, O Verhagen, C Segeren, et al.
Leukemia|August 2, 2017
Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trialH Goldschmidt, H M Lokhorst, E K Mai, et al.
Pageof 4